Neurolytic celiac plexus block enhances skeletal muscle insulin signaling and attenuates insulin resistance in GK rats

Li,Jun; Chen,Tao; Li,Kun; Yan,Hongtao; Li,Xiaowei; Yang,Yun; Zhang,Yulan; Su,Bingyin; Li,Fuxiang

doi:10.3892/etm.2016.3087

Neurolytic celiac plexus block enhances skeletal muscle insulin signaling and attenuates insulin resistance in GK rats

Authors:
- Jun Li
- Tao Chen
- Kun Li
- Hongtao Yan
- Xiaowei Li
- Yun Yang
- Yulan Zhang
- Bingyin Su
- Fuxiang Li
View Affiliations

Affiliations: Department of Anesthesiology, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China, General Surgery Center, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China, Medical Laboratory Center, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China, Department of Urology, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China, Development and Regeneration Key Laboratory of Sichuan, Chengdu Medical College, Chengdu, Sichuan 610083, P.R. China, Department of ICU, Chengdu Military General Hospital, Chengdu, Sichuan 610083, P.R. China
Published online on: February 19, 2016 https://doi.org/10.3892/etm.2016.3087
Pages: 2033-2041

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑insulin‑dependent diabetes mellitus (NIDDM) is associated with chronic inflammatory activity and disrupted insulin signaling, leading to insulin resistance (IR). The present study investigated the benefits of neurolytic celiac plexus block (NCPB) on IR in a rat NIDDM model. Goto‑Kakizaki rats fed a high‑fat, high‑glucose diet to induce signs of NIDDM were randomly divided into NCPB and control groups; these received daily bilateral 0.5% lidocaine or 0.9% saline injections into the celiac plexus, respectively. Following 14 and 28 daily injections, rats were subject to oral glucose tolerance tests (OGTTs) or sacrificed for the analysis of serum free fatty acids (FFAs), serum inflammatory cytokines and skeletal muscle insulin signaling. Compared with controls, rats in the NCPB group demonstrated significantly (P<0.05) lower baseline, 60‑min and 120‑min OGTT values, lower 120‑min serum insulin, lower IR [higher insulin sensitivity index (ISI1) and lower ISI2) and lower serum FFAs, tumor necrosis factor‑α, interleukin (IL)‑1β and IL‑6. Conversely, NCPB rats exhibited higher basal and insulin‑stimulated skeletal muscle glucose uptake and higher skeletal muscle insulin receptor substrate‑1 (IRS‑1) and glucose transporter type 4 expression. There were no differences between the groups in insulin receptor β (Rβ) or Akt expression; however Rβ‑Y1162/Y1163 and Akt‑S473 phosphorylation levels were higher and IRS‑1‑S307 phosphorylation were lower in NCPB rats than in the controls. These results indicate that NCPB improved insulin signaling and reduced IR, possibly by inhibiting inflammatory cytokine release.

View Figures

View References

1	Chen L, Magliano DJ and Zimmet PZ: The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol. 8:228–236. 2011. View Article : Google Scholar : PubMed/NCBI
2	Brunetti A, Chiefari E and Foti D: Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes. 5:128–140. 2014.PubMed/NCBI
3	Montane J, Cadavez L and Novials A: Stress and the inflammatory process: A major cause of pancreatic cell death in type 2 diabetes. Diabetes Metab Syndr Obes. 7:25–34. 2014.PubMed/NCBI
4	Mandrup-Poulsen T: Type 2 diabetes mellitus: A metabolic autoinflammatory disease. Dermatol Clin. 31:495–506. 2013. View Article : Google Scholar : PubMed/NCBI
5	Eguchi K and Manabe I: Macrophages and islet inflammation in type 2 diabetes. Diabetes Obes Metab. 15(Suppl 3): 152–158. 2013. View Article : Google Scholar : PubMed/NCBI
6	Richardson VR, Smith KA and Carter AM: Adipose tissue inflammation: Feeding the development of type 2 diabetes mellitus. Immunobiology. 218:1497–1504. 2013. View Article : Google Scholar : PubMed/NCBI
7	Mackenzie RW and Elliott BT: Akt/PKB activation and insulin signaling: A novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes Metab Syndr Obes. 7:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
8	McPhee JB and Schertzer JD: Immunometabolism of obesity and diabetes: Microbiota link compartmentalized immunity in the gut tometabolic tissue inflammation. Clin Sci (Lond). 129:1083–1096. 2015. View Article : Google Scholar : PubMed/NCBI
9	Tanti JF, Ceppo F, Jager J and Berthou F: Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol (Lausanne). 8:1812013.
10	Jaiswal N, Gunaganti N, Maurya CK, Narender T and Tamrakar AK: Free fatty acid induced impairment of insulin signaling is prevented by the diastereomeric mixture of calophyllic acid and isocalophyllic acid in skeletal muscle cells. Eur J Pharmacol. 746:70–77. 2015. View Article : Google Scholar : PubMed/NCBI
11	Luo C, Yang H, Tang C, Yao G, Kong L, He H and Zhou Y: Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats. Int Immunopharmacol. 28:744–750. 2015. View Article : Google Scholar : PubMed/NCBI
12	McCall KD, Holliday D, Dickerson E, Wallace B, Schwartz AL, Schwartz C, Lewis CJ, Kohn LD and Schwartz FL: Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. J Endocrinol. 207:343–353. 2010. View Article : Google Scholar : PubMed/NCBI
13	Yang FR, Wu BS, Lai GH, Wang Q, Yang LQ, He MW and Ni JX: Assessment of consecutive neurolytic celiac plexus block (NCPB) technique outcomes in the management of refractory visceral cancer pain. Pain Med. 13:518–521. 2012. View Article : Google Scholar : PubMed/NCBI
14	Li J, Wei XH, Lin L, Che JX, Qiu QM, Zuo HT, An H, Liu YH, Bai SR and Tian FZ: Effect of neurolytic celiac plexus block on insulin resistance after partial hepatectomy in rats. Zhongguo Ji Jiu Yi Xue. 33:1124–1126. 2013.(In Chinese).
15	Akash MS, Rehman K and Chen S: Goto-Kakizaki rats: Its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus. Curr Diabetes Rev. 9:387–396. 2013. View Article : Google Scholar : PubMed/NCBI
16	Portha B, Giroix MH, Tourrel-Cuzin C, Le-Stunff H and Movassat J: The GK rat: A prototype for the study of non-overweight type 2 diabetes. Methods Mol Biol. 933:125–159. 2012.PubMed/NCBI
17	Chen R, Wang L, Cao HW, Tang CW, Bai XZ and Ji QH: Expression of GLP-1 receptor mRNA in intestine and pancreas of diabetic rats. Di 4 Jun Yi Da Xue Xue Bao. 29:1235–1238. 2008.(In Chinese).
18	Li J, Yan HT, Che JX, Bai SR, Qiu QM, Ren L, Pan F, Sun XQ, Tian FZ, Li DX and Tang LJ: Effects of neurolytic celiac plexus block on liver regeneration in rats with partial hepatectomy. PLoS One. 8:e731012013. View Article : Google Scholar : PubMed/NCBI
19	Wincey C and Marks V: A micro-method for measuring glucose using the autoanalyzer and glucose-oxidase. J Clin Pathol. 14:558–559. 1961. View Article : Google Scholar : PubMed/NCBI
20	Banerji MA, Chaiken RL, Gordon D, Kral JG and Lebovitz HE: Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes. 44:141–146. 1995. View Article : Google Scholar : PubMed/NCBI
21	Ellis L, Clauser E, Morgan DO, Edery M, Roth RA and Rutter WJ: Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell. 45:721–732. 1986. View Article : Google Scholar : PubMed/NCBI
22	Cherqui G, Reynet C, Caron M, Melin B, Wicek D, Clauser E, Capeau J and Picard J: Insulin receptor tyrosine residues 1162 and 1163 control insulin stimulation of myristoyl-diacylglycerol generation and subsequent activation of glucose transport. J Biol Chem. 265:21254–21261. 1990.PubMed/NCBI
23	Virkamäki A, Ueki K and Kahn CR: Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest. 103:931–943. 1999. View Article : Google Scholar : PubMed/NCBI
24	Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE and White MF: Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem. 277:1531–1537. 2002. View Article : Google Scholar : PubMed/NCBI
25	Hsueh WA and Buchanan TA: Obesity and hypertension. Endocrinol Metab Clin North Am. 23:405–427. 1994.PubMed/NCBI
26	Elmendorf JS, Damrau-Abney A, Smith TR, David TS and Turinsky J: Phosphatidylinositol 3-kinase and dynamics of insulin resistance in denervated slow and fast muscles in vivo. Am J Physiol. 272:E661–E670. 1997.PubMed/NCBI
27	Lee J and Pilch PF: The insulin receptor: Structure, function and signaling. Am J Physiol. 266:C319–C334. 1994.PubMed/NCBI
28	Kobayashi M, Iwanishi M, Egawa K and Shigeta Y: Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes. 41:476–483. 1992. View Article : Google Scholar : PubMed/NCBI
29	Ola MS: Effect of hyperglycemia on insulin receptor signaling in the cultured retinal Müller glial cells. Biochem Biophys Res Commun. 444:264–269. 2014. View Article : Google Scholar : PubMed/NCBI
30	Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M and Kahn CR: Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol. 21:319–329. 2001. View Article : Google Scholar : PubMed/NCBI
31	Lehr S, Kotzka J, Herkner A, Sikmann A, Meyer HE, Krone W and Müller-Wieland D: Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro. Biochemistry. 39:10898–10907. 2000. View Article : Google Scholar : PubMed/NCBI
32	Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF and Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 271:665–668. 1996. View Article : Google Scholar : PubMed/NCBI
33	Aguirre V, Uchida T, Yenush L, Davis R and White MF: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser (307). J Biol Chem. 275:9047–9054. 2000. View Article : Google Scholar : PubMed/NCBI
34	Anderson KE, Coadwell J, Stephens LR and Hawkins PT: Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr Biol. 8:684–691. 1998. View Article : Google Scholar : PubMed/NCBI
35	Cao S, Li B, Yi X, Chang B, Zhu B, Lian Z, Zhang Z, Zhao G, Liu H and Zhang H: Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes. PLoS One. 7:e517092012. View Article : Google Scholar : PubMed/NCBI
36	He L, Simmen FA, Mehendale HM, Ronis MJ and Badger TM: Chronic ethanol intake impairs insulin signaling in rats by disrupting Akt association with the cell membrane. Role of TRB3 in inhibition of Akt/protein kinase B activation. J Biol Chem. 281:11126–11134. 2006. View Article : Google Scholar : PubMed/NCBI
37	Rea S and James DE: Moving GLUT4: The biogenesis and trafficking of GLUT4 storage vesicles. Diabetes. 46:1667–1677. 1997. View Article : Google Scholar : PubMed/NCBI
38	Mueckler M: Facilitative glucose transporters. Eur J Biochem. 219:713–725. 1994. View Article : Google Scholar : PubMed/NCBI
39	Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE and Lodish HF: Sequence and structure of a human glucose transporter. Science. 229:941–945. 1985. View Article : Google Scholar : PubMed/NCBI
40	Kahn BB: Facilitative glucose transporters: Regulatory mechanisms and dysregulation in diabetes. J Clin Invest. 89:1367–1374. 1992. View Article : Google Scholar : PubMed/NCBI
41	Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM and Ciaraldi TP: Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest. 87:1072–1081. 1991. View Article : Google Scholar : PubMed/NCBI
42	Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J and Thériault R: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest. 97:2705–2713. 1996. View Article : Google Scholar : PubMed/NCBI
43	Calle MC and Fernandez ML: Inflammation and type 2 diabetes. Diabetes Metab. 38:183–191. 2012. View Article : Google Scholar : PubMed/NCBI
44	Donath MY: Inflammation as a sensor of metabolic stress in obesity and type 2 diabetes. Endocrinology. 152:4005–4006. 2011. View Article : Google Scholar : PubMed/NCBI
45	Borst SE: The role of TNF-alpha in insulin resistance. Endocrine. 23:177–182. 2004. View Article : Google Scholar : PubMed/NCBI
46	Qi C and Pekala PH: Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. Proc Soc Exp Biol Med. 223:128–135. 2000. View Article : Google Scholar : PubMed/NCBI
47	Kanety H, Feinstein R, Papa MZ, Hemi R and Karasik A: Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem. 270:23780–23784. 1995. View Article : Google Scholar : PubMed/NCBI
48	Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H and Zick Y: A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem. 272:29911–29918. 1997. View Article : Google Scholar : PubMed/NCBI
49	Heydrick SJ, Jullien D, Gautier N, Tanti JF, Giorgetti S, Van Obberghen E and Le Marchand-Brustel Y: Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest. 91:1358–1366. 1993. View Article : Google Scholar : PubMed/NCBI
50	Stephens JM, Lee J and Pilch PF: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem. 272:971–976. 1997. View Article : Google Scholar : PubMed/NCBI
51	Wang CN, O'Brien L and Brindley DN: Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes. 47:24–31. 1998. View Article : Google Scholar : PubMed/NCBI
52	Hauner H, Petruschke T, Russ M, Röhrig K and Eckel J: Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia. 38:764–771. 1995. View Article : Google Scholar : PubMed/NCBI
53	Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K and Olefsky JM: TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes. 46:1678–1683. 1997. View Article : Google Scholar : PubMed/NCBI
54	Lang CH, Dobrescu C and Bagby GJ: Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 130:43–52. 1992. View Article : Google Scholar : PubMed/NCBI
55	Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, et al: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 277:50230–50236. 2002. View Article : Google Scholar : PubMed/NCBI
56	Hotamisligil GS and Spiegelman BM: Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes. 43:1271–1278. 1994. View Article : Google Scholar : PubMed/NCBI
57	Takaesu G, Ninomiya-Tsuji J, Kishida S, Li X, Stark GR and Matsumoto K: Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway. Mol Cell Biol. 21:2475–2484. 2001. View Article : Google Scholar : PubMed/NCBI
58	Emanuelli B, Glondu M, Filloux C, Peraldi P and Van Obberghen E: The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells. Diabetes. 53(Suppl 3): S97–S103. 2004. View Article : Google Scholar : PubMed/NCBI
59	Rui L, Yuan M, Frantz D, Shoelson S and White MF: SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 277:42394–42398. 2002. View Article : Google Scholar : PubMed/NCBI
60	Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, et al: MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem. 276:19800–19806. 2001. View Article : Google Scholar : PubMed/NCBI
61	Eguez L, Lee A, Chavez JA, Miinea CP, Kane S, Lienhard GE and McGraw TE: Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab. 2:263–272. 2005. View Article : Google Scholar : PubMed/NCBI
62	Jager J, Grémeaux T, Cormont M, Le Marchand-Brustel Y and Tanti JF: Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology. 148:241–251. 2007. View Article : Google Scholar : PubMed/NCBI
63	Kim JA, Yeh DC, Ver M, Li Y, Carranza A, Conrads TP, Veenstra TD, Harrington MA and Quon MJ: Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: Cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance. J Biol Chem. 280:23173–23183. 2005. View Article : Google Scholar : PubMed/NCBI
64	Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J and Caron M: Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: Prevention by rosiglitazone. Biochem Biophys Res Commun. 311:372–379. 2003. View Article : Google Scholar : PubMed/NCBI
65	Senn JJ, Klover PJ, Nowak IA and Mooney RA: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 51:3391–3399. 2002. View Article : Google Scholar : PubMed/NCBI
66	Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS and Friedman JE: Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem. 277:23301–23307. 2002. View Article : Google Scholar : PubMed/NCBI